Dendreon Corporation (DNDN): Is Time Running Out for This Fallen Biotech?
There’s a lot to notice from Johnson & Johnson (NYSE:JNJ)’s earnings -- the company announced a very solid quarter.
Medivation Inc. (MDVN)
Market is closed
News
- First
- << Previous
- 31 - 40
- Next >>
Medivation Inc (MDVN), Onyx Pharmaceuticals, Inc. (ONXX): Biotechs Take a Dive After a Standout Start to 2013
Are investors hitting the brakes on biotech? The biotech sector's one of the most boom-or-bust areas for investors, where fortunes can be won or lost.
Hedge Funds Are Buying Incyte Corporation (INCY)
If you'd ask most investors, hedge funds are seen as underperforming, outdated financial tools of years past.
Dendreon Corporation (DNDN): This Cancer Drug Developer Could Really Use a Partner
As we've learned over the past few years, getting a drug approved by the Food and Drug Administration is just half the battle in the biotech sector.
UnitedHealth Group Inc. (UNH), Aetna Inc. (AET): The Eight Biggest Health Problems Americans Face
The Centers for Disease Control and Prevention would put heart disease at the top of the list, since it's the leading cause of death in the nation.
Dendreon Corporation (DNDN) Searching For A Rebound
Where have we heard the fourth-quarter-comeback plan before? Oh yes, from Johnson's predecessor who issued 2011 revenue guidance of $350 million to $400 million, with half of that coming in the fourth...
Dendreon Corporation (DNDN): What You Should Know
What: Shares of Dendreon Corporation (NASDAQ:DNDN) -- developer of the Food and Drug Administration-approved immunotherapy treatment Provenge to treat castration-resistant prostate cancer -- sank like...
Will Dendreon Corporation (DNDN) Ever Make Money?
On Thursday, Dendreon Corporation (NASDAQ:DNDN) will release its latest quarterly results.
Avanir Pharmaceuticals, Inc. (AVNR), Medivation Inc (MDVN) & This Week In Biotech
With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Johnson & Johnson (JNJ): This Company's Biggest Drug Rivals
What doesn't J&J produce? From pharmaceuticals to consumer care goods to medical devices, this major medical player has it all.
- First
- << Previous
- 31 - 40
- Next >>
Billionaire Hedge Funds
